Proton Beam Therapy in India 2026: Availability, Costs and Which Cancers Benefit Most

State-of-the-art Indian proton therapy centre with gantry equipment and African patient on treatment table with radiation oncologist

Proton Beam Therapy in India 2026: Availability, Costs and Which Cancers Benefit Most

Radiation therapy has been a cornerstone of cancer treatment for over a century. From rudimentary X-ray machines to modern intensity-modulated radiotherapy (IMRT), the technology has advanced enormously. But conventional photon radiation has a fundamental physical limitation: X-rays deposit energy throughout their path, meaning both tumour and surrounding healthy tissue receive radiation.

Proton beam therapy changes this physics. Protons — the positively charged particles in atomic nuclei — deliver the majority of their energy at a precise, controllable depth (the "Bragg peak"), with minimal dose beyond that point. The result is dramatically reduced radiation to healthy tissue while delivering full dose to the tumour.

For decades, proton therapy was available only in a handful of centres globally, mostly in the USA and Europe, at costs exceeding $100,000 per patient. India's entry into this field — particularly with the Apollo Proton Cancer Centre in Chennai — has made this precision treatment accessible to African patients for the first time.

The Physics Advantage: Why Protons Matter

Understanding why proton therapy represents an advance requires a brief physics explanation.

Conventional X-ray (photon) radiation:
X-ray beams deposit energy throughout their path — entering from outside the body, maximum dose near the entry point, continuing through the tumour, and then through healthy tissue on the far side. Techniques like IMRT use multiple beams from different angles to concentrate dose at the tumour, but healthy tissue still receives significant dose.

Proton radiation:
Protons travel through tissue depositing relatively low dose, then release the majority of their energy in a sharp peak (the Bragg peak) at a depth determined by the initial proton energy. Beyond this peak, proton dose drops to nearly zero. The depth of the Bragg peak is controlled precisely by the treatment planning system.

Clinical implication:

  • Organs in front of the tumour receive normal proton dose (similar to photons)
  • The tumour receives full therapeutic dose
  • Organs behind the tumour receive near-zero dose — this is where proton therapy's advantage lies

This is particularly critical when the tumour is adjacent to the spinal cord, heart, brainstem, optic nerves, or cochlea, or when the patient is a child whose developing tissues are especially sensitive to radiation.

Conditions Where Proton Therapy Provides Clear Benefit

Paediatric brain tumours

Children with medulloblastoma, ependymoma, craniopharyngioma, and other brain tumours requiring radiation benefit most from proton therapy. Conventional radiation to the developing brain causes cognitive impairment, growth hormone deficiency, and second cancer risk. Proton therapy reduces these long-term effects significantly.

For African families with children diagnosed with brain tumours, proton therapy in India represents access to a treatment that was previously available only in the USA or Germany.

Skull base tumours

Chordomas and chondrosarcomas at the skull base are notoriously difficult to treat due to their proximity to the brainstem, cranial nerves, and carotid arteries. Proton therapy's sharp dose falloff allows higher doses to these tumours while protecting surrounding critical structures.

Meningioma (near critical structures)

Some benign meningiomas recur and require radiation. Those adjacent to the optic apparatus, brainstem, or cochlea benefit from proton precision.

Brain metastases (select cases)

Whole brain radiotherapy with proton reduces dose to hippocampus, preserving memory function better than conventional whole-brain treatment.

Prostate cancer

The rectum lies immediately posterior to the prostate. Conventional radiation to the prostate inevitably doses the rectum, causing bowel side effects. Proton therapy's Bragg peak can be positioned to stop within the prostate, dramatically reducing rectal dose and improving quality of life outcomes.

Head and neck cancers

Cancers of the oropharynx, larynx, and salivary glands are often treated with radiation to wide fields including multiple lymph node regions. Conventional radiation causes salivary gland damage (dry mouth), difficulty swallowing, and hearing loss. Proton therapy spares these structures more effectively.

Thoracic tumours (lung, oesophagus)

Heart and spinal cord dose reduction is possible with proton therapy for some thoracic malignancies.

Liver cancer (hepatocellular carcinoma)

Stereotactic body proton therapy for HCC offers liver dose reduction compared to photon SBRT.

Re-irradiation

For patients who have previously received radiation and require re-treatment, proton therapy allows a second course of definitive radiation to be delivered with reduced cumulative dose to previously irradiated healthy tissue.

Where Proton Therapy is Available in India

Apollo Proton Cancer Centre (Chennai)
Opened in 2019 and India's first and currently most established proton therapy centre. Uses IBA Proteus PLUS technology with pencil beam scanning — the same generation of technology used at major US proton centres. Located within the Apollo Hospitals network in Chennai with full oncology multidisciplinary support.

Manipal Comprehensive Cancer Centre (Bengaluru)
Proton therapy operational as of 2025. Expanding capacity with growing clinical experience.

HCG Cancer Centre (Multiple Cities)
HCG operates India's largest dedicated cancer hospital network and is expanding proton therapy availability across its network.

Additional centres under development:
Multiple health groups including Tata Medical and Fortis are developing proton therapy facilities, with expected commissioning 2026-2028.

Costs for Proton Therapy in India

Indication Fractions India Cost USA Cost
Paediatric brain tumour (craniospinal) 30-35 fractions $35,000–50,000 $100,000–150,000
Skull base chordoma 70-74 CGE $40,000–55,000 $100,000–160,000
Prostate cancer 20-39 fractions $20,000–35,000 $60,000–100,000
Head and neck cancer 30-35 fractions $25,000–40,000 $80,000–120,000
Liver HCC (SBPT) 3-5 fractions $15,000–25,000 $40,000–80,000

These costs are for proton therapy alone and do not include concurrent chemotherapy, surgery, or systemic treatments that may be part of the overall plan.

The Treatment Process: What Patients Experience

Week 1 — Evaluation and simulation:
On arrival, you undergo a CT simulation scan — a planning scan taken with you positioned exactly as you will be during treatment. Immobilisation devices (custom mask, cradle) are made to ensure identical positioning each day. Treatment planning begins, typically taking 1-2 weeks.

Weeks 2-8 — Daily treatment:
Proton therapy is delivered Monday through Friday, one session per day. Each session takes 15-45 minutes including set-up time. The beam delivery itself takes 5-15 minutes. You feel nothing during treatment — protons are invisible and the experience is identical to lying for a conventional X-ray.

Monitoring:
Weekly assessments with the radiation oncologist. Blood counts and relevant tests as indicated. Management of any treatment-related side effects.

Weeks 8-10 — Completion and assessment:
Post-treatment scans scheduled at appropriate intervals. Discharge documentation prepared for your oncologist at home.

Is Proton Therapy Right for Your Case?

Proton therapy is not appropriate for every cancer patient. For many cancers, modern conventional IMRT delivers equivalent outcomes at significantly lower cost. A systematic evaluation is required.

Indications that proton therapy may be appropriate for you:

  • Paediatric patient requiring radiation to the brain or spine
  • Tumour adjacent to brainstem, spinal cord, optic nerves, or cochlea
  • Re-irradiation case
  • Prostate cancer with significant rectal comorbidity
  • Your radiation oncologist has specifically recommended proton therapy

The evaluation process at Apollo Chennai includes review of your imaging, pathology, and previous treatment by the radiation oncologist, who will confirm whether proton or conventional radiation is indicated for your specific case.

Getting Started with Proton Therapy in India

Begin your inquiry at /intake with your diagnosis, staging, and description of your treatment plan to date. If proton therapy has been recommended, our clinical team will coordinate with Apollo Chennai or another appropriate centre for a rapid case review.

Compare overall cancer treatment costs in India vs Western countries to understand the full financial picture of your treatment journey.

Proton therapy represents the current frontier of radiation oncology. In 2026, it is no longer accessible only to patients in wealthy countries. India's proton centres exist — and Arodya can help you reach them.

Share this article

Frequently Asked Questions

Ready to explore treatment options in India?

Get a free case review from our coordinators within 24 hours. No commitment required.